Latest Strategic Reviews News

Page 3 of 60
Dexus has forecast lower FY27 earnings while refocusing its business on office, industrial, retail and selected alternatives. The ASX-listed real estate group is also targeting more than A$2 billion of capital release, but remains exposed to infrastructure fund liquidity issues and the unresolved APAC appeal.
Eva Park
Eva Park
28 Oct 2026
Turnstone Resources has completed portfolio-wide magnetic surveys in Sweden and begun reviewing strategic options for its German potash assets, while its September cash balance covered less than one quarter of reported outgoings. The ASX-listed explorer also secured A$1.1 million in placement commitments and expects lower corporate costs ahead.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Big River Industries has carried its FY26 recovery into the new financial year, reporting 10.5% first-quarter revenue growth and a further lift in gross margin. The building-products group says its growth initiatives support above-market expansion, while a strategic review remains unresolved.
Victor Sage
Victor Sage
28 Oct 2026
Encounter Resources has grown its Aileron niobium resource by 54% to 120 million tonnes while moving the West Arunta project into mining lease, metallurgical and development work. The company also ended FY2026 with $26.9 million in cash and term deposits, but still has no Ore Reserves or operating revenue base.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Elixir Energy has reported encouraging early flow results from its Lorelle-3H appraisal well while securing a $205 million strategic farmout with Beach Energy. The deal offers a four-year funding pathway, but the well’s post-soak performance and transaction completion remain important next tests.
Victor Sage
Victor Sage
27 Oct 2026
Cynata Therapeutics ended September with just A$175,000 in cash after a A$1.316 million quarterly operating drain, but says sweeping cuts and fresh funding could extend its runway into FY2028. The biotech has now reduced its workforce to zero, repaid its R&D loan and shifted focus to finding value for its Cymerus platform.
Ada Torres
Ada Torres
27 Oct 2026
Botanix’s Sofdra prescriptions rose 5.3% in the September quarter, but flat net revenue and a sharp cash decline have forced a major reset. The company is targeting a roughly 50% reduction in operating expenses while assessing licensing, acquisitions and broader strategic transactions.
Victor Sage
Victor Sage
27 Oct 2026
Premier Investments’ FY26 profit from continuing operations fell 10.3% as Smiggle sales weakened, while Peter Alexander delivered another record year. The retailer is entering FY27 with cleaner inventory, a stronger dividend and a costly UK retreat still to absorb.
Victor Sage
Victor Sage
23 Oct 2026
Sierra Nevada Gold has started a 25,000-metre second-phase drilling campaign at its As Safra copper-gold project in Saudi Arabia, with the first assay results due in November. The company is directing capital and management attention to Saudi Arabia while exploring commercial options for its Nevada portfolio.
Maxwell Dee
Maxwell Dee
21 Oct 2026
Woodside delivered a stronger third quarter as production rose 12% and operating revenue reached US$4.281 billion. Scarborough is now 99% complete and remains on track for its first LNG cargo in Q4, while the company moves to reduce its Beaumont New Ammonia investment.
Maxwell Dee
Maxwell Dee
21 Oct 2026
Findi says it has not secured financing or restructuring terms acceptable to the relevant parties, while its cash runway remains short and its ASX suspension continues. The company cannot provide a date for lodging its FY2026 audited accounts or Annual Report.
Claire Turing
Claire Turing
21 Oct 2026
Ovanti sharply reduced its quarterly operating cash outflow to A$491,096, helped by higher customer receipts and cost reductions. But with only A$227,000 in cash, the ASX-listed fintech remains dependent on further funding, operating receipts and uncertain legal recoveries.
Victor Sage
Victor Sage
20 Oct 2026

Browse the archive

Full archive